Alembic Pharmaceutical informed the bourses that it has got approval for its Abbreviated New Drug Application (ANDA) Desvenlafaxine Extended-Release Tablets, 25 mg from USFDA on Monday.

Large-cap pharma company Glenmark Pharma received USFDA approval for its Estradiol Vaginal Inserts USP, 10 mcg which is a generic version of VAGIFEM, 10 mcg of Novo Nordisk Inc. to help lessen vaginal symptoms of menopause.

Shri Bajrang Power and Ispat Limited plans to launch an IPO comprising of equity shares of face value Rs. 10 each, amounting to a total of Rs. 500 crore. The company filed a DRHP with SEBI on September 12, 2018.

Some agents convince people to go for corporate fixed deposits by saying that you will receive 2-3 per cent higher returns than that of bank fixed deposits without any risks. It is very important to understand any investment product before getting into it. So let's find out what actually corporate fixed deposits are and whether they really a safe option?

Following stocks are close to their 52-week low as at 1.09 p.m. on September 17, 2018.

The markets on September 17, 2018 opened gap down. BSE Sensex is trading at 37,689.69, down by 400.95 points and the Nifty is trading at 11,408.85, down by 106.35 points. 

The stock of Tata Consultancy Services (TCS) was buzzing on Monday following the news. The stock has been gaining for the last 2 days and has risen 1.14 per cent in the period.

Overall volumes in futures & options currently stand at 65.03 lakh contracts with a turnover of Rs. 6,12,453.58 crore.

Overall volumes in futures & options currently stand at 65.03 lakh contracts with a turnover of Rs. 6,12,453.58 crore.

The opening upside gap area (11,381-11,431) which was formed September 14 is likely to act as a key support zone from the near term perspective. Stocks in news: RCF, Sterlite Technologies, Reliance Industries, Infosys, Wipro, MEP Infrastructure Developers, Gammon India and Future Supply Chain Solutions.